Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05546892
Other study ID # COL-2
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 10, 2023
Est. completion date September 2025

Study information

Verified date March 2023
Source N.N. Petrov National Medical Research Center of Oncology
Contact Aleksei Karachun
Phone +79219462123
Email dr.a.karachun@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to determine if short-term outcomes of colon resections after full bowel preparation (mechanical bowel preparation plus oral antibiotics) are superior to colon resections with no bowel preparation.


Description:

The design involves random allocation of eligible patients to full bowel preparation or no bowel preparation in 1:1 ratio. After that colon resection is performed in both groups. Short-term outcomes are assessed in 30 day period after surgery. This is a superiority trial evaluating statistical superiority. Rate of anastomotic leak is anticipated to decrease from 8% (data from local registry) to 3%. For power of 80% enrolment of 586 patients is required. The intent-to-treat principle is used for the data analysis.


Recruitment information / eligibility

Status Recruiting
Enrollment 586
Est. completion date September 2025
Est. primary completion date September 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - histologically confirmed adenocarcinoma of the colon (caecum, ascending, transverse, descending, sigmoid) - clinical stage T1-4aN0-2M0-1 (distant metastases must be resectable) - indications for surgical colonic resection - ECOG status 0-2 - At least 18 years of age - Written informed consent Exclusion Criteria: - Medical or psychiatric conditions that compromise the patient's ability to give informed consent or comply with the study protocol - Pregnancy or breast feeding - Medical contraindications for surgical treatment - Any use of antibiotics 30 days prior to inclusion - Functioning stoma - Contraindications for use of MBP or OA drugs or their components - Indications for mandatory MBP (planned intraoperative colonoscopy etc) - Indications for obstructive resection - Acute bowel obstruction, bleeding or perforation - Other malignancies not in remission

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Full bowel preparation prior to colon resection for cancer
Mechanical bowel preparation and oral antibiotics
No bowel preparation
Omission of any bowel preparation

Locations

Country Name City State
Russian Federation N.N. Petrov National Medical Research Center of Oncology Saint Petersburg

Sponsors (1)

Lead Sponsor Collaborator
N.N. Petrov National Medical Research Center of Oncology

Country where clinical trial is conducted

Russian Federation, 

Outcome

Type Measure Description Time frame Safety issue
Primary Anastomotic leak rate Rate of anastomotic leak in patients after colon resections 30 days
Secondary Surgical site infection (SSI) rate Rate of Surgical site infection 30 days
Secondary Intraabdominal and or pelvic abscess rate Rate of intraabdominal and or pelvic abscess 30 days
Secondary Overall morbidity Rate of patients with any complications after surgery 30 days
Secondary Rate of intraoperative complications Rate of patients with intraoperative complications Duration of surgical procedure
Secondary Surgery duration in minutes Time of surgical procedure Duration of surgical procedure
Secondary Quality of bowel preparation assessed by surgeon Assessment of bowel preparation quality by surgeon (qualitative scale) Day of surgical procedure
Secondary Bowel preparation compliance Rate of patients in experimental arm undergoing complete bowel preparation according to protocol Day of surgical procedure
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Completed NCT03457454 - Reducing Rural Colon Cancer Disparities
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT04088955 - A Digimed Oncology PharmacoTherapy Registry
Recruiting NCT06010862 - Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors Phase 1
Terminated NCT01347645 - Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer Phase 1/Phase 2
Completed NCT03390907 - Hybrid APC Assisted EMR for Large Colon Polyps N/A
Recruiting NCT03175224 - APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors Phase 2
Completed NCT04079478 - The AID Study: Artificial Intelligence for Colorectal Adenoma Detection
Active, not recruiting NCT04057274 - Acute Effect of modeRate-intensity aerOBIc Exercise on Colon Cancer Cell Growth N/A
Recruiting NCT03190941 - Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients Phase 1/Phase 2
Not yet recruiting NCT05147545 - Impact of Exercise and Hyperlipidic Meal on Free Circulating DNA in Patients With Metastatic Colonic Cancer and Healthy Subjects N/A
Recruiting NCT05026268 - The Laparoscopic Right Colectomy With Intracoroporeal Anastomosis N/A
Not yet recruiting NCT03277235 - Effect of a Resilience Model-Based Care Plan in Newly Diagnosed Colorectal Cancer Patients N/A
Active, not recruiting NCT02730702 - Colon Cancer Risk-stratification Via Optical Analysis of Rectal Ultrastructure
Active, not recruiting NCT02959541 - PK/PD Investigation of Calciumfolinat in Blood, Tumor and Adjacent Mucosa in Patient With Colon Cancer N/A
Completed NCT02810652 - Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection N/A
Recruiting NCT02577627 - Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC N/A
Terminated NCT02628535 - Safety Study of MGD009 in B7-H3-expressing Tumors Phase 1
Recruiting NCT02526836 - Complete Mesocolic Excision With Central Vessel Ligation Compared With Conventional Surgery for Colon Cancer Phase 2/Phase 3